X4 Pharmaceuticals, Inc Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • X4 Pharmaceuticals, Inc Return On Equity for the quarter ending June 30, 2024 was 32.9 %.
  • X4 Pharmaceuticals, Inc annual Return On Equity for 2023 was -170 %, a 2.29% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Return On Equity for 2022 was -174 %, a 59.7% decline from 2021.
  • X4 Pharmaceuticals, Inc annual Return On Equity for 2021 was -109 %, a 69.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -170 +3.98 +2.29% Jan 1, 2023 Dec 31, 2023
2022 -174 -65.1 -59.7% Jan 1, 2022 Dec 31, 2022
2021 -109 -44.7 -69.4% Jan 1, 2021 Dec 31, 2021
2020 -64.4 -1.1 -1.74% Jan 1, 2020 Dec 31, 2020
2019 -63.3 -116 -220% Jan 1, 2019 Dec 31, 2019
2018 52.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.